Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis
Annals of Hematology · 2025
DOI: 10.1007/s00277-025-06236-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2025. Verfasst von Anna L Bode und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Opiate Overdose, Analgesics, Opioid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sickle cell disease (SCD) predominantly affects individuals of African descent and is characterized by frequent painful vaso-occlusive crises, often requiring opioid management. With the opioid epidemic raising concerns about opioid overdose, this study examines in-hospital outcomes among SCD and non-SCD patients hospitalized for opioid overdose. Using the National Inpatient Sample (NIS) from 2016 to 2021, we analyzed 479,175 opioid overdose hospitalizations, including 1,315 (0.3%) with a concomitant diagnosis of SCD. Propensity score matching was used to balance demographics, comorbidities, and hospital characteristics. SCD patients were younger (45.3% aged 30–49 vs. 33.1%, p < 0.001), predominantly of African descent (92.1% vs. 14.1%, p < 0.001), and more often from lower-income households (58.4% vs. 35.2%, p < 0.001). SCD patients had lower rates of mechanical ventilation (aOR: 0.7, 95% CI: 0.6–0.9) and anoxic brain injury (aOR: 0.5, 95% CI: 0.4–0.8) but experienced longer hospital stays and higher costs. No significant differences in in-hospital mortality were observed (aOR: 0.89, 95% CI: 0.7–1.1, p = 0.34). These findings emphasize the need for a nuanced approach to managing SCD patients during opioid overdose hospitalizations, focusing on mitigating complications, addressing prolonged hospital stays and higher costs, and reducing healthcare disparities through tailored strategies informed by the unique needs of this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
- Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA. oborjamontes@salud.unm.edu.
- Department of Family and Community Health, West Virginia University, Morgantown, WV, USA.
- Montefiore St. Luke's Cornwall Hospital, Newburg, NY, USA.
- Department of Surgery, University of New Mexico, Albuquerque, NM, USA.
- Associate Clinical Investigator, Honor Health Research Institute, Scottsdale, AZ, USA.
Zitieren
APA
Bode, A. L., Borja-Montes, O. F., Quazi, M. A., Mumtaz, A., Sohail, A. H., Smith, C. R., Khawaja, M. R., & Sheikh, A. B. (2025). Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis. Annals of Hematology. https://doi.org/10.1007/s00277-025-06236-x
Vancouver
Bode AL, Borja-Montes OF, Quazi MA, Mumtaz A, Sohail AH, Smith CR, et al. Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis. Annals of Hematology. 2025. doi:10.1007/s00277-025-06236-x
BibTeX
@article{Bode2025,
author = {Bode, Anna L and Borja-Montes, Oscar F and Quazi, Mohammed A and Mumtaz, Aqsa and Sohail, Amir H and Smith, Christopher R and Khawaja, Muhammad Rizwan and Sheikh, Abu Baker},
title = {Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis},
journal = {Annals of Hematology},
year = {2025},
doi = {10.1007/s00277-025-06236-x}
}
EUVIMED